VOLUNTEER

HELP YOURSELF AND OTHERS


 

The Johns Hopkins Psilocybin Research Project study team is pleased to report that enrollment for this study has now been completed.
We are optimistic about initiating a follow-up study in cancer patients in 2016.

ABOUT US

Matthew W. Johnson, Ph.D.

Associate Professor, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine


Education:
  • 1998: B.S., Eastern Oregon University, Psychology
  • 2002: M.A., University of Vermont, General/Experimental Psychology, Biobehavioral Specialization
  • 2004: Ph.D., University of Vermont, General/Experimental Psychology, Biobehavioral Specialization
  • 2004-2007: Post-doctoral Fellowship, Johns Hopkins University School of Medicine, Behavioral Pharmacology
Areas of Specialization:
  • Human behavioral pharmacology
  • Behavioral economics of drug self-administration
  • Delay discounting and impulsivity in drug dependence
  • Atypical drugs of abuse (e.g., hallucinogens)
  • Drug administration studies: alcohol, benzodiazepines, caffeine, cocaine, GHB, nicotine, psilocybin
Academic Positions:
  • 1999 - 2004: Pre-doctoral Fellow, National Institute on Drug Abuse, Human Behavioral Pharmacology Laboratory, University of Vermont
  • 2004 - 2007: Post-doctoral Fellow, National Institute on Drug Abuse, Behavioral Pharmacology Research Unit, Johns Hopkins University School of Medicine
  • 2007 - 2009: Faculty Instructor, Behavioral Pharmacology Research Unit, Department of Psychiatry, Johns Hopkins University School of Medicine
  • 2009 - 2013: Assistant Professor, Behavioral Pharmacology Research Unit, Department of Psychiatry, Johns Hopkins University School of Medicine
  • 2013 - present: Associate Professor, Behavioral Pharmacology Research Unit, Department of Psychiatry, Johns Hopkins University School of Medicine
View Full Biography